Tanzania’s largest bank — a ~26% ROE compounder — that has already delivered its cheap re-rating. The case from here is earnings-driven compounding, not another multiple expansion.
CRDB delivered record FY2025 profit after tax of TZS 724.6bn (+31%) on a TZS 22.2tn balance sheet, with a cost-to-income ratio of 41.7%, a non-performing-loan ratio of just 2.97%, and a return on equity around 26%. It is the broadest, most profitable banking franchise on the Dar es Salaam Stock Exchange. The catch is price: after a powerful multi-year run, the shares trade at ~9.6× earnings and ~2.5× book — versus the ~5.5× / ~1.45× that made them a deep-value buy two years ago.
This is not Vodacom. There is no accounting distortion to exploit and no obvious mispricing; on a justified price-to-book of ~2.8× (ROE ~26%, cost of equity ~17%, growth ~12%), the stock sits close to fair value. What remains is high-quality compounding: at ~26% ROE and a ~33% payout, the franchise can grow book value ~18% a year and pay a ~3.4% dividend — a prospective total return in the high teens to low twenties, with no re-rating required.
Four pillars — three on quality, one a deliberate caution on price.
The largest bank in Tanzania: TZS 22.2tn assets and TZS 14.68tn deposits across retail, corporate, SME and treasury, with the country’s broadest distribution. Scale begets low funding costs and operating leverage.
~26% ROE, a 41.7% cost-to-income ratio, and a 2.97% NPL ratio — top-tier efficiency and asset quality. Profit grew 31% with EPS rising to TZS 277 from 211.
At ~26% ROE retaining ~two-thirds of earnings, book value can compound ~18% a year; the ~33% payout adds a ~3.4% yield. The return engine is internal, not dependent on the market re-rating the stock.
From ~5.5× / 1.45× to ~9.6× / 2.5×, the cheap-entry portion is captured. On a justified P/B the stock is roughly fair. We are buyers of compounding on weakness, not chasers of momentum.
A fast-growing, profitable, still-underbanked banking sector in a ~6% GDP economy — with CRDB and NMB the two dominant earners.
| Tanzanian banking · CY2025 (Bank of Tanzania) | Value |
|---|---|
| Banking-sector assets | TZS 79.4tn |
| Sector profit (YoY) | TZS 2.62tn · +21% |
| CRDB share of sector assets (~) | ~28% |
| GDP growth · inflation | ~6% · ~3.3% |
The structural story is formalisation and digitisation: a young, growing, still-underbanked population moving onto digital banking and credit, with the largest balance sheets capturing the most low-cost deposits and the best risk-adjusted lending. CRDB and NMB together dominate the industry’s earnings; CRDB leads on assets.
A universal bank — retail, corporate, SME, treasury — with a regional arm and an insurance broker, and a leading digital franchise.
| Corporate snapshot | |
|---|---|
| Listing | DSE: CRDB |
| Shares in issue (~) | 2.61 billion |
| Market cap (~, Jun 26) | ~TZS 6.9tn |
| Subsidiaries | CRDB Bank Burundi S.A. · CRDB Insurance Broker |
| Year-end | 31 December |
| Balance sheet (FY2025) | |
|---|---|
| Total assets | TZS 22.2tn (+8.6%) |
| Customer deposits | TZS 14.68tn (+5.5%) |
| Shareholders’ funds | ~TZS 2.78tn (12.5% of assets) |
| NPL ratio | 2.97% |
| Cost-to-income | 41.7% |
CRDB is the most broadly diversified bank in the country, combining a large retail and SME base with corporate and treasury operations, a growing digital channel (SimBanking, agency banking), a Burundi subsidiary, and an insurance-broking arm. The breadth of the franchise is the source of both its low-cost funding and its resilience through the cycle.
An illustrative five-year model anchored to FY2025 actuals and conservative ROE-led assumptions — profit growth tapering from the +31% FY2025 base toward the low-teens as the book scales.
| Driver | FY26E | FY27E | FY28E | FY29E | FY30E |
|---|---|---|---|---|---|
| PAT growth | +18% | +16% | +15% | +14% | +13% |
| ROE | 26% | 25% | 25% | 24% | 24% |
| Dividend payout | ~33% | ~33% | ~34% | ~34% | ~35% |
| TZS bn | FY25A | FY26E | FY27E | FY28E | FY29E | FY30E |
|---|---|---|---|---|---|---|
| Profit after tax | 724.6 | 855 | 992 | 1,141 | 1,301 | 1,470 |
| EPS (TZS) | 277 | 327 | 380 | 437 | 498 | 563 |
| DPS (TZS) | 90 | 108 | 125 | 149 | 169 | 197 |
| ROE | ~26% | 26% | 25% | 25% | 24% | 24% |
| Total assets (TZS tn) | 22.2 | 24.4 | 26.9 | 29.6 | 32.5 | 35.8 |
Illustrative only — projections rest on assumptions that may not be realised. PAT taper from the +31% FY2025 base; EPS on ~2.61bn shares; DPS at a ~33–35% payout; assets compounding ~10%. FY2025 figures are audited reported results.
The return is created internally — by compounding a high ROE through a growing, well-funded book — and harvested through a rising dividend.
~26% ROE retaining ~two-thirds of earnings grows book value ~18% a year — the core engine, independent of the market’s multiple.
The largest deposit franchise funds lending cheaply; scale and digital channels keep the cost-to-income ratio low (41.7%).
The Burundi subsidiary and insurance-broking arm add growth and fee income beyond the core Tanzanian bank.
A ~33% payout on compounding earnings lifts the cash dividend year after year — yield on cost rises even if the price does little.
With the re-rating done, value is added by entry discipline — accumulating on weakness so the compounding is bought at a sensible multiple.
The risks are those of a large, re-rated bank — credit, rates, and valuation — each manageable, none hidden.
| Risk | Severity | Mitigant |
|---|---|---|
| Valuation — re-rated, less margin of safety | HIGH | Buy on weakness; the ~26% ROE + dividend underwrites a return without further re-rating; trim into strength. |
| Credit cycle & concentration (large book) | MEDIUM | NPLs at 2.97% with conservative provisioning; diversified retail/SME/corporate exposure. |
| Rate cycle / NIM compression | MEDIUM | Low-cost deposit base cushions margins; scale supports pricing through the BoT cycle. |
| Regional execution (Burundi, expansion) | MEDIUM | Small share of group today; optionality, not a load-bearing assumption. |
| TZS depreciation (USD-equivalent return) | MEDIUM | Returns underwritten in TZS; domestic earner; size within a diversified sleeve. |
| Regulation / capital requirements | LOWER | Well-capitalised (equity 12.5% of assets); established regulatory relationship. |
A liquid, large-cap name — accumulate with patience and price discipline rather than urgency.
| Term | Proposed approach |
|---|---|
| Instrument | Ordinary shares — DSE: CRDB |
| Stance | Accumulate on weakness; hold the core; trim into strength |
| Accumulation zone | ~TZS 2,200–2,400 (below ~9× earnings) |
| Trim zone | ~TZS 3,000–3,500 and above (toward ~12× earnings) |
| Liquidity | Among the most liquid DSE names — easier entry/exit than most |
| Income | ~33% payout; rising dividend, ~3.4% current yield |
| Horizon | Multi-year core holding — a compounder, not a trade |
Indicative only; subject to diligence, prevailing DSE liquidity, transaction charges and final approval.
Banks are valued on earnings, book, and dividends — not unlevered DCF. We triangulate P/E, justified price-to-book, and a dividend-and-growth return, then frame it against the ~TZS 2,650 price.
| Input | Value |
|---|---|
| Sustainable ROE | ~26% |
| Cost of equity (TZS) | ~17% |
| Long-run growth (g) | ~12% |
| Justified P/B = (ROE−g)/(COE−g) | ~2.8× |
| Implied value (BVPS ~1,053) | ~2,950 |
Justified P/B of ~2.8× vs a current ~2.5× implies the stock is roughly fair to modestly cheap — not the deep discount of two years ago.
| Method | Implied |
|---|---|
| P/E 8× (FY25 EPS 277) | 2,216 |
| P/E 10× | 2,770 |
| P/E 12× | 3,324 |
| P/B 2.8× (justified) | 2,948 |
| Current market | ~2,650 |
Peer banks trade ~8–12× earnings (NMB ~8.6×). CRDB sits mid-range on superior scale and ROE.
| Metric | CRDB | NMB | Sector |
|---|---|---|---|
| FY25 profit (TZS bn) | 724.6 | 760 | 2,620 (total) |
| Total assets (TZS tn) | 22.2 | 17.6 | 79.4 |
| ROE | ~26% | ~high-20s | — |
| NPL ratio | 2.97% | ~3% | — |
| Trailing P/E | ~9.6× | ~8.6× | 8–12× |
CRDB is the asset leader; NMB the profit leader and slightly cheaper on P/E. Both are quality compounders; the choice is scale-and-breadth (CRDB) vs profitability-and-momentum (NMB).
Scale 0–3,500. The market (~2,650) already sits inside the fair-value zone — the honest read is that the valuation upside is modest; the return is the compounding.
| Scenario | Exit P/E | EPS CAGR | Exit price | Total return p.a. |
|---|---|---|---|---|
| Downside | 8× | +12% | ~3,100 | ~8% |
| Base | ~9.5× | +16% | ~4,150 | ~18% |
| Upside | 11× | +18% | ~5,000 | ~25% |
Base: P/E roughly held, EPS compounds ~16%, plus a ~3.4% rising dividend → high-teens total return without re-rating. Returns in TZS; USD outcomes lower by expected currency depreciation.
We recommend accumulating CRDB on weakness as a core, multi-year compounder — not chasing it on strength. This is a genuinely great bank: the largest in Tanzania, ~26% ROE, a 41.7% cost-to-income ratio, a 2.97% NPL ratio, and a rising dividend. But the cheap-entry portion of the investment has been captured; at ~9.6× earnings and ~2.5× book, against a justified P/B of ~2.8×, the stock is roughly fair. The forward return — a prospective high-teens-to-low-twenties total — comes from earnings compounding and the dividend, not another re-rating.
Arthur G. Kanza